These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25980951)

  • 1. Small molecule inhibitor of apoptosis proteins antagonists: a patent review.
    Hird AW; Aquila BM; Hennessy EJ; Vasbinder MM; Yang B
    Expert Opin Ther Pat; 2015 Jul; 25(7):755-74. PubMed ID: 25980951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule pan-IAP antagonists: a patent review.
    Flygare JA; Fairbrother WJ
    Expert Opin Ther Pat; 2010 Feb; 20(2):251-67. PubMed ID: 20100005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smac mimetics as IAP antagonists.
    Fulda S
    Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
    Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
    Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
    Zhu H; Li Y; Liu Y; Han B
    ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
    Ali R; Singh S; Haq W
    Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways: targeting death receptors and smac mimetics.
    Fulda S
    Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of bivalent Smac-based peptides as antagonists of XIAP and development and validation of a fluorescence polarization assay for XIAP containing both BIR2 and BIR3 domains.
    Nikolovska-Coleska Z; Meagher JL; Jiang S; Kawamoto SA; Gao W; Yi H; Qin D; Roller PP; Stuckey JA; Wang S
    Anal Biochem; 2008 Mar; 374(1):87-98. PubMed ID: 18023397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis.
    Manzoni L; Belvisi L; Bianchi A; Conti A; Drago C; de Matteo M; Ferrante L; Mastrangelo E; Perego P; Potenza D; Scolastico C; Servida F; Timpano G; Vasile F; Rizzo V; Seneci P
    Bioorg Med Chem; 2012 Nov; 20(22):6687-708. PubMed ID: 23036335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
    Beug ST; Conrad DP; Alain T; Korneluk RG; Lacasse EC
    Int J Dev Biol; 2015; 59(1-3):141-7. PubMed ID: 26374535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport.
    Talbott RL; Borzilleri RM; Chaudhry C; Fargnoli J; Shen H; Fairchild C; Barnhart B; Ortega M; McDonagh TE; Vuppugalla R; Vite GD; Hunt JT; Gottardis M; Naglich JG
    Exp Cell Res; 2015 Nov; 338(2):251-60. PubMed ID: 26302264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing Smac-mimetics as antagonists of XIAP, cIAP1, and cIAP2.
    Cossu F; Mastrangelo E; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    Biochem Biophys Res Commun; 2009 Jan; 378(2):162-7. PubMed ID: 18992220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.
    Cong H; Xu L; Wu Y; Qu Z; Bian T; Zhang W; Xing C; Zhuang C
    J Med Chem; 2019 Jun; 62(12):5750-5772. PubMed ID: 30676015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.
    Lecis D; Mastrangelo E; Belvisi L; Bolognesi M; Civera M; Cossu F; De Cesare M; Delia D; Drago C; Manenti G; Manzoni L; Milani M; Moroni E; Perego P; Potenza D; Rizzo V; Scavullo C; Scolastico C; Servida F; Vasile F; Seneci P
    Bioorg Med Chem; 2012 Nov; 20(22):6709-23. PubMed ID: 23062821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
    Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
    J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Immuno-Modulatory Effects of Inhibitor of Apoptosis Protein Antagonists in Cancer Immunotherapy.
    Michie J; Kearney CJ; Hawkins ED; Silke J; Oliaro J
    Cells; 2020 Jan; 9(1):. PubMed ID: 31947615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways: targeting inhibitor of apoptosis proteins in cancer--from molecular mechanism to therapeutic application.
    Fulda S
    Clin Cancer Res; 2014 Jan; 20(2):289-95. PubMed ID: 24270683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.